Literature DB >> 15536497

Human cocaine-seeking behavior and its control by drug-associated stimuli in the laboratory.

Leigh V Panlilio1, Sevil Yasar, Ro Nemeth-Coslett, Jonathan L Katz, Jack E Henningfield, Marcello Solinas, Stephen J Heishman, Charles W Schindler, Steven R Goldberg.   

Abstract

Second-order schedules of drug self-administration were developed to incorporate the effects of drug-related environmental stimuli into an animal model of drug abuse, making it more similar to human situations. Ironically, little is known about how human subjects behave under these schedules. In this study, human volunteers with a history of cocaine use worked on a second-order schedule in which every 100th lever response produced an auditory-visual brief stimulus (2 s). The first stimulus produced after 1 h was extended to 10 s and paired with an intravenous injection of cocaine (25 mg). Up to three injections were allowed per session. In different phases of the experiment, presentation of the brief stimulus was discontinued and/or saline solution (placebo) was injected instead of cocaine. Injections of cocaine were found to maintain responding even when the brief stimulus was not presented. Placebo injections alone did not maintain responding. In contrast, the brief stimulus maintained high levels of responding under placebo conditions, even though self-reports indicated that subjects could clearly discriminate that they were not receiving cocaine. These results demonstrate that drug-related environmental stimuli can maintain persistent drug seeking during periods of drug unavailability. As this procedure directly measures the effects of stimuli on drug seeking, it may provide a valuable complement to indirect measures, such as self-reports of craving, that are often used with human subjects. The similarity of the response patterns in humans and animals also supports the use of second-order schedules in animals as a valid model of human drug seeking.

Entities:  

Mesh:

Year:  2005        PMID: 15536497     DOI: 10.1038/sj.npp.1300599

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  25 in total

1.  Brand differences of free-base nicotine delivery in cigarette smoke: the view of the tobacco industry documents.

Authors:  G Ferris Wayne; G N Connolly; J E Henningfield
Journal:  Tob Control       Date:  2006-06       Impact factor: 7.552

2.  Randomized trial of prize-based reinforcement density for simultaneous abstinence from cocaine and heroin.

Authors:  Udi E Ghitza; David H Epstein; John Schmittner; Massoud Vahabzadeh; Jia-Ling Lin; Kenzie L Preston
Journal:  J Consult Clin Psychol       Date:  2007-10

3.  The Novel μ-Opioid Receptor Antagonist GSK1521498 Decreases Both Alcohol Seeking and Drinking: Evidence from a New Preclinical Model of Alcohol Seeking.

Authors:  Chiara Giuliano; Charles R Goodlett; Daina Economidou; Maria P García-Pardo; David Belin; Trevor W Robbins; Edward T Bullmore; Barry J Everitt
Journal:  Neuropsychopharmacology       Date:  2015-06-05       Impact factor: 7.853

4.  Nicotine as a typical drug of abuse in experimental animals and humans.

Authors:  Bernard Le Foll; Steven R Goldberg
Journal:  Psychopharmacology (Berl)       Date:  2005-10-05       Impact factor: 4.530

Review 5.  Nicotine self-administration research: the legacy of Steven R. Goldberg and implications for regulation, health policy, and research.

Authors:  Jack E Henningfield; Tracy T Smith; Bethea A Kleykamp; Reginald V Fant; Eric C Donny
Journal:  Psychopharmacology (Berl)       Date:  2016-10-21       Impact factor: 4.530

Review 6.  Individual variation in resisting temptation: implications for addiction.

Authors:  Benjamin T Saunders; Terry E Robinson
Journal:  Neurosci Biobehav Rev       Date:  2013-02-21       Impact factor: 8.989

7.  Discriminative stimulus and reinforcing effects of p-fluoro-L-deprenyl in monkeys.

Authors:  Sevil Yasar; Jozsef Gaal; Zuzana Justinova; Jack Bergman
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

Review 8.  Dopamine ups and downs in vulnerability to addictions: a neurodevelopmental model.

Authors:  Marco Leyton; Paul Vezina
Journal:  Trends Pharmacol Sci       Date:  2014-04-30       Impact factor: 14.819

9.  The associative basis of cue-elicited drug taking in humans.

Authors:  Lee Hogarth; Anthony Dickinson; Theodora Duka
Journal:  Psychopharmacology (Berl)       Date:  2009-12-04       Impact factor: 4.530

Review 10.  Effects of nicotine in experimental animals and humans: an update on addictive properties.

Authors:  Bernard Le Foll; Steven R Goldberg
Journal:  Handb Exp Pharmacol       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.